DFM:NIH Statistics

Total Valuation

DFM:NIH has a market cap or net worth of AED 515.94 million. The enterprise value is 521.30 million.

Market Cap	515.94M
Enterprise Value	521.30M

Important Dates

The last earnings date was Tuesday, March 31, 2026.

Earnings Date	Mar 31, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	245.64M
Shares Outstanding	n/a
Shares Change (YoY)	+1.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.55%
Owned by Institutions (%)	n/a
Float	154.24M

Valuation Ratios

The trailing PE ratio is 22.68.

PE Ratio	22.68
Forward PE	n/a
PS Ratio	6.57
PB Ratio	0.87
P/TBV Ratio	0.98
P/FCF Ratio	23.22
P/OCF Ratio	23.06
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.35, with an EV/FCF ratio of 23.46.

EV / Earnings	22.92
EV / Sales	6.64
EV / EBITDA	22.35
EV / EBIT	24.01
EV / FCF	23.46

Financial Position

The company has a current ratio of 4.95, with a Debt / Equity ratio of 0.04.

Current Ratio	4.95
Quick Ratio	4.62
Debt / Equity	0.04
Debt / EBITDA	1.13
Debt / FCF	1.19
Interest Coverage	8.12

Financial Efficiency

Return on equity (ROE) is 3.90% and return on invested capital (ROIC) is 4.06%.

Return on Equity (ROE)	3.90%
Return on Assets (ROA)	2.03%
Return on Invested Capital (ROIC)	4.06%
Return on Capital Employed (ROCE)	3.38%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.12
Inventory Turnover	4.11

Taxes

In the past 12 months, DFM:NIH has paid 75,730 in taxes.

Income Tax	75,730
Effective Tax Rate	0.33%

Stock Price Statistics

The stock price has decreased by -5.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.06%
50-Day Moving Average	1.59
200-Day Moving Average	1.74
Relative Strength Index (RSI)	70.88
Average Volume (20 Days)	12,796

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DFM:NIH had revenue of AED 78.57 million and earned 22.75 million in profits. Earnings per share was 0.09.

Revenue	78.57M
Gross Profit	43.57M
Operating Income	21.72M
Pretax Income	22.62M
Net Income	22.75M
EBITDA	23.33M
EBIT	21.72M
Earnings Per Share (EPS)	0.09

Balance Sheet

The company has 86.35 million in cash and 26.36 million in debt, giving a net cash position of 59.98 million.

Cash & Cash Equivalents	86.35M
Total Debt	26.36M
Net Cash	59.98M
Net Cash Per Share	n/a
Equity (Book Value)	591.12M
Book Value Per Share	2.14
Working Capital	91.92M

Cash Flow

In the last 12 months, operating cash flow was 22.37 million and capital expenditures -150,398, giving a free cash flow of 22.22 million.

Operating Cash Flow	22.37M
Capital Expenditures	-150,398
Depreciation & Amortization	1.61M
Net Borrowing	-2.79M
Free Cash Flow	22.22M
FCF Per Share	n/a

Margins

Gross margin is 55.45%, with operating and profit margins of 27.64% and 28.95%.

Gross Margin	55.45%
Operating Margin	27.64%
Pretax Margin	28.79%
Profit Margin	28.95%
EBITDA Margin	29.69%
EBIT Margin	27.64%
FCF Margin	28.28%

Dividends & Yields

DFM:NIH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	1.01%
Buyback Yield	-1.03%
Shareholder Yield	-1.03%
Earnings Yield	4.41%
FCF Yield	4.31%

Dividend Details

Stock Splits

The last stock split was on August 5, 2025. It was a forward split with a ratio of 1.06.

Last Split Date	Aug 5, 2025
Split Type	Forward
Split Ratio	1.06

Scores

DFM:NIH has an Altman Z-Score of 4.23 and a Piotroski F-Score of 5.

Altman Z-Score	4.23
Piotroski F-Score	5